Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.
about
Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@en
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@nl
type
label
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@en
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@nl
prefLabel
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@en
Beta blocker use correlates wi ...... cy of immunotherapies in mice.
@nl
P2093
P2860
P1433
P1476
Beta blocker use correlates wi ...... acy of immunotherapies in mice
@en
P2093
Carla Schmeck
Elizabeth A Repasky
Jeffrey M Sivik
Joseph J Drabick
Junjia Zhu
Todd D Schell
Ying Zhang
P2860
P304
P356
10.1080/2162402X.2017.1405205
P577
2017-12-21T00:00:00Z